JP2002519340A - 甲状腺ホルモン類似体およびそれらの調製方法 - Google Patents

甲状腺ホルモン類似体およびそれらの調製方法

Info

Publication number
JP2002519340A
JP2002519340A JP2000557229A JP2000557229A JP2002519340A JP 2002519340 A JP2002519340 A JP 2002519340A JP 2000557229 A JP2000557229 A JP 2000557229A JP 2000557229 A JP2000557229 A JP 2000557229A JP 2002519340 A JP2002519340 A JP 2002519340A
Authority
JP
Japan
Prior art keywords
compound
hydrogen
alkyl
formula
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000557229A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002519340A5 (https=
Inventor
トーマス、 エス． スキャンラン、
ヒカリ、 エー．、 アイ． ヨシハラ、
グラズィア チエリニ、
ティモシー、 ジェイ． ミチソン、
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of JP2002519340A publication Critical patent/JP2002519340A/ja
Publication of JP2002519340A5 publication Critical patent/JP2002519340A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/16—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2000557229A 1998-06-30 1999-06-28 甲状腺ホルモン類似体およびそれらの調製方法 Withdrawn JP2002519340A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9118598P 1998-06-30 1998-06-30
US60/091,185 1998-06-30
PCT/US1999/014627 WO2000000468A1 (en) 1998-06-30 1999-06-28 Thyroid hormone analogues and methods for their preparation

Publications (2)

Publication Number Publication Date
JP2002519340A true JP2002519340A (ja) 2002-07-02
JP2002519340A5 JP2002519340A5 (https=) 2006-08-31

Family

ID=22226506

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000557229A Withdrawn JP2002519340A (ja) 1998-06-30 1999-06-28 甲状腺ホルモン類似体およびそれらの調製方法

Country Status (13)

Country Link
US (1) US6107517A (https=)
EP (2) EP1598334A1 (https=)
JP (1) JP2002519340A (https=)
KR (1) KR20010053277A (https=)
AT (1) ATE293595T1 (https=)
AU (1) AU4840199A (https=)
CA (1) CA2335551C (https=)
DE (1) DE69924846T2 (https=)
DK (1) DK1089968T3 (https=)
ES (1) ES2241294T3 (https=)
IL (1) IL140140A0 (https=)
PT (1) PT1089968E (https=)
WO (1) WO2000000468A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511084A (ja) * 1997-06-18 2002-04-09 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 選択性甲状腺ホルモン類似体

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
CA2374266A1 (en) * 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
CA2374260A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
WO2002056880A1 (en) * 2001-01-19 2002-07-25 Cytokinetics, Inc. Triphenylmethane kinesin inhibitors
US7302347B2 (en) * 2002-12-10 2007-11-27 The Regents Of The University Of California Method for creating specific, high affinity nuclear receptor pharmaceuticals
SE526033C3 (sv) * 2003-11-06 2009-12-08 Metso Paper Inc Silanordning och silkorg för silning av massasuspensioner
WO2006128058A2 (en) 2005-05-26 2006-11-30 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
CN1882327A (zh) 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
WO2006128056A2 (en) * 2005-05-26 2006-11-30 Metabasis Therapeutics, Inc. Novel phosphinic acid-containing thyromimetics
WO2007002036A1 (en) * 2005-06-24 2007-01-04 Thomas Lavin Tyroid hormone in burn and adipose deposites
WO2014178892A1 (en) 2013-05-03 2014-11-06 Scanlan Thomas S Use of sobetirome in the treatment of x-linked adrenolenoleukodystrophy
CN109475121B (zh) 2016-05-18 2021-06-25 俄勒冈健康科学大学 苏比替罗衍生物
CA3044059A1 (en) 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
US11707472B2 (en) 2017-06-05 2023-07-25 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
ES3053674T3 (en) 2018-03-22 2026-01-23 Viking Therapeutics Inc Crystalline forms and methods of producing crystalline forms of a compound
WO2020117962A1 (en) 2018-12-05 2020-06-11 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation
EP3894383A1 (en) 2018-12-12 2021-10-20 Autobahn Therapeutics, Inc. Novel thyromimetics
CA3130371A1 (en) 2019-03-01 2020-09-10 Autobahn Therapeutics, Inc. Novel thyromimetics
KR20220121239A (ko) 2019-11-29 2022-08-31 아우토반 쎄라퓨틱스, 인크. 신규한 갑상선 호르몬 모방제
WO2021257851A1 (en) 2020-06-17 2021-12-23 Autobahn Therapeutics, Inc. Thyromimetics
JP7813730B2 (ja) 2020-06-17 2026-02-13 オートバーン セラピューティクス，インク． 甲状腺様作用剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3332957A (en) * 1964-09-02 1967-07-25 Ciba Geigy Corp Amino esters of substituted phenoxy acetic acids
JPS5195049A (en) * 1975-02-12 1976-08-20 * **********so*****no***tsu*****************************************ni*no
US4323691A (en) * 1979-10-09 1982-04-06 Abbott Laboratories Hydroxyaminomethyl derivatives of benzoyl di-substituted α-phenoxyalkanoyl esters
US5883294A (en) * 1997-06-18 1999-03-16 The Regeants Of The University Of California Selective thyroid hormone analogs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6009023451, Ｇｒａｚｉａ Ｃｈｉｅｌｌｉｎｉ ｅｔ ａｌ．, Ｃｈｅｍｉｓｔｒｙ ＆ Ｂｉｏｌｏｇｙ, 19980522, ｖｏｌ．５ ｎｏ．６, ｐｐ．２９９−３０６ *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511084A (ja) * 1997-06-18 2002-04-09 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 選択性甲状腺ホルモン類似体

Also Published As

Publication number Publication date
IL140140A0 (en) 2002-02-10
KR20010053277A (ko) 2001-06-25
EP1089968B1 (en) 2005-04-20
EP1598334A1 (en) 2005-11-23
PT1089968E (pt) 2005-08-31
ES2241294T3 (es) 2005-10-16
CA2335551C (en) 2009-03-03
CA2335551A1 (en) 2000-01-06
AU4840199A (en) 2000-01-17
WO2000000468A1 (en) 2000-01-06
ATE293595T1 (de) 2005-05-15
US6107517A (en) 2000-08-22
DE69924846T2 (de) 2006-04-27
DK1089968T3 (da) 2005-08-22
EP1089968A4 (en) 2002-08-21
EP1089968A1 (en) 2001-04-11
DE69924846D1 (de) 2005-05-25

Similar Documents

Publication Publication Date Title
JP2002519340A (ja) 甲状腺ホルモン類似体およびそれらの調製方法
EP0991618B1 (en) Selective thyroid hormone analogs
KR100294381B1 (ko) 헤테로아세트산유도체
JP2002519340A5 (https=)
JP4425921B2 (ja) シクロオキシゲナーゼ−２インヒビターとして作用するジアリール２−（５ｈ）−フラノンの酸化窒素放出プロドラッグ
JPH0725730B2 (ja) 細胞分化の誘発に有効な化合物の製法
US20040087632A1 (en) Anilino liver X-receptor modulators
JP2724114B2 (ja) トリテルペン誘導体およびそれを含有するエンドセリンレセプター拮抗剤
US6822120B2 (en) Sulfone liver X-receptor modulators
WO2021257851A1 (en) Thyromimetics
EP0540400A1 (fr) Dérivés de quinoléine, utile comme angiotensine II antagonistes
EA023638B1 (ru) Производные 1-{4-(5-арил-[1,2,4]-оксадиазол-3-ил)бензил}пиперидин-4-илкарбоновой кислоты в качестве агонистов s1p1 рецепторов
WO2011017907A1 (zh) 氮杂环丁酮类化合物及医药应用
JPH07502271A (ja) 新規なｂｈｔエーテル化合物および脂血減少及び抗アテローム性動脈硬化剤としてのこれらの使用
EP0433064A1 (en) Naphthylsulfonylalkanoic acid compounds
JP2025508025A (ja) Ｄｈｃｒ２４阻害化合物
JPH10182597A (ja) 異性化ビタミンｄ誘導体
CN113880747A (zh) 一种吲哚衍生物及其应用
JP2002161100A (ja) ４−アルコキシ−２，３，６−トリメチルフェニルマンノシド類及びこれを含有する医薬
LT3339B (en) New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
CZ396891A3 (cs) Thiofenylalkanové kyseliny, způsob výroby a farmaceutické prostředky sjejich obsahem
JPH08505148A (ja) ロイコトリエンアンタゴニストとして有用な置換ピリジル化合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060628

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060628

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090519

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090813

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090820

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100323

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20100622